Diamantopoulos, P. T., Symeonidis, A., Pappa, V., Kotsianidis, I., Galanopoulos, A., Pontikoglou, C., Anagnostopoulos, A., Vassilopoulos, G., Zikos, P., Hatzimichael, E., Papaioannou, M., Megalakaki, A., Repousis, P., Kotsopoulou, M., Dimou, M., Solomou, E., Dryllis, G., Tsokanas, D., Papoutselis, M., Papageorgiou, S., Kyrtshonis, M., Kourakli, A., Papadaki, H., Panayiotidis, P., & Viniou, N. (2021). the effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes. British journal of haematology, 192, 978–987. http://access.bl.uk/ark:/81055/vdc_100123974561.0x000061